ADCYAP1 and encephalomyelitis: The potent anti-inflammatory properties of exogenous PACAP have been demonstrated in experimental models of human arthritis [6] and encephalomyelitis [7], for instance, but data regarding beneficial effects exerted by synthetic PACAP in the gut are limited.